A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

NCT07474727 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: AMT-676
DRUG: 5-FU
DRUG: Leucovorin
DRUG: Bevacizumab
DRUG: Cetuximab
DRUG: Irinotecan
DRUG: Oxaliplatin

Sponsor

Multitude Therapeutics Inc.